Evidence map›Paper›PMID 32687633›Full record

ArticleThe Prostate2020

Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry.

Peggi M Angel, Laura Spruill, Melanie Jefferson, Jennifer R Bethard, Lauren E Ball, Chanita Hughes-Halbert, Richard R Drake

Open access · greenAbstract read
In one paragraph

Article in The Prostate, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Reviewing the Regulators of COL1A1.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peggi M AngelDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Proteomics Center, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-4436-555X
Laura SpruillDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0003-1895-5203
Melanie JeffersonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-7865-4168
Jennifer R BethardDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Proteomics Center, Medical University of South Carolina, Charleston, South Carolina.
Lauren E BallDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Proteomics Center, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-6780-1679
Chanita Hughes-HalbertDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-0103-6916
Richard R DrakeDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Proteomics Center, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-7279-6349
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
Sociobiological Responses to Stress in Prostate Cancer SurvivorsU54MD010706 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ETHIER, STEPHEN P., HUGHES-HALBERT, CHANITA A. · 2016 to 2020
$8.0M
Orbitrap Fusion Lumos ETD Mass SpectrometerS10OD025126 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2018 to 2018
$991k
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal ProteinsR21CA240148 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ANGEL, PEGGI M · 2019 to 2020
$480k
NCI NIH HHS P30 CA138313NCI NIH HHS P30CA138313NCI NIH HHS R21 CA240148NCI NIH HHS R21CA240148NHLBI NIH HHS T32 HL007260NIGMS NIH HHS P20 GM103542NIGMS NIH HHS P20GM103542NIH HHS S10 OD010731NIH HHS S10OD010731NIH HHS S10 OD025126NIH HHS S10OD025126NIH HHS U54MD010706NIMHD NIH HHS U54 MD010706
6 · The paper itself

Abstract

backgroundThe emergence of reactive stroma is a hallmark of prostate cancer (PCa) progression and a potential source for prognostic and diagnostic markers of PCa. Collagen is a main component of reactive stroma and changes systematically and quantitatively to reflect the course of PCa, yet has remained undefined due to a lack of tools that can define collagen protein structure. Here we use a novel collagen-targeting proteomics approach to investigate zonal regulation of collagen-type proteins in PCa prostatectomies.

methodsProstatectomies from nine patients were divided into zones containing 0%, 5%, 20%, 70% to 80% glandular tissue and 0%, 5%, 25%, 70% by mass of PCa tumor following the McNeal model. Tissue sections from zones were graded by a pathologist for Gleason score, percent tumor present, percent prostatic intraepithelial neoplasia and/or inflammation (INF). High-resolution accurate mass collagen targeting proteomics was done on a select subset of tissue sections from patient-matched tumor or nontumor zones. Imaging mass spectrometry was used to investigate collagen-type regulation corresponding to pathologist-defined regions.

resultsComplex collagen proteomes were detected from all zones. COL17A and COL27A increased in zones of INF compared with zones with tumor present. COL3A1, COL4A5, and COL8A2 consistently increased in zones with tumor content, independent of tumor size. Collagen hydroxylation of proline (HYP) was altered in tumor zones compared with zones with INF and no tumor. COL3A1 and COL5A1 showed significant changes in HYP peptide ratios within tumor compared with zones of INF (2.59 ± 0.29, P value: .015; 3.75 ± 0.96 P value .036, respectively). By imaging mass spectrometry COL3A1 showed defined localization and regulation to tumor pathology. COL1A1 and COL1A2 showed gradient regulation corresponding to PCa pathology across zones. Pathologist-defined tumor regions showed significant increases in COL1A1 HYP modifications compared with COL1A2 HYP modifications. Certain COL1A1 and COL1A2 peptides could discriminate between pathologist-defined tumor and inflammatory regions.

conclusionsSite-specific posttranslational regulation of collagen structure by proline hydroxylation may be involved in reactive stroma associated with PCa progression. Translational and posttranslational regulation of collagen protein structure has potential for new markers to understand PCa progression and outcomes.

Indexed as

Protein Processing, Post-TranslationalAgedAmino Acid SequenceAutoantigensCollagenCollagen Type ICollagen Type I, alpha 1 ChainCollagen Type IIICollagen Type IVCollagen Type VIIICollagen Type XVIIDisease ProgressionFibrillar CollagensHumansHydroxylationMaleAutoantigensCOL1A2 protein, humanCOL3A1 protein, humanCOL4A5 protein, humanCOL8A2 protein, humanCollagenCollagen Type ICollagen Type I, alpha 1 ChainCollagen Type IIICollagen Type IVCollagen Type VIIICollagen Type XVIIFibrillar CollagensNeoplasm ProteinsNon-Fibrillar CollagensProlinecollagenformalin-fixedimaging mass spectrometryMALDI imaging mass spectrometryparaffin-embedded tissue imagingpeptide imagingproline hydroxylationprostate adenocarcinomaprostate cancerproteomicstissue imaging

Identifiers

PMID32687633
PMCPMC7857723
OpenAlexW3043936143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.